MICK
Financiado
Translational Microbiome Platform
Dysbiosis (the imbalance of the microbial community that resides within and upon us) can affect health and represents a risk factor for the genesis and evolution of a plethora of chronic diseases and pathologies. The analysis of t...
Dysbiosis (the imbalance of the microbial community that resides within and upon us) can affect health and represents a risk factor for the genesis and evolution of a plethora of chronic diseases and pathologies. The analysis of the microbiome is necessary to detect, assess and monitor it. Nevertheless, microbiome analysis and its application to the clinical field is very complex, expensive, and time-consuming.
We created MICK, the first digital decision support system helping healthcare professionals in integrating microbiome analysis into clinical practice. MICK automated platform analyses microbiome raw data in real-time, with the highest accuracy and translates it into evidence-based analytics, insights, and practical recommendations.
MICK allows customers (clinical centres and diagnostics labs) to scale their service offering to patients without any upfront investment, determining up to 75% cost reduction and faster TAT compared to existing solutions.
ver más
Duración del proyecto: 24 meses
Fecha Inicio: 2022-08-31
Fecha Fin: 2024-08-31
Fecha Fin: 2024-08-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-08-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIC-2021-ACCELERATOROPEN-01:
EIC Accelerator Open 2021
Cerrada
hace 2 años
Presupuesto
El presupuesto total del proyecto asciende a
3M€
Líder del proyecto
SEQUENTIA BIOTECH
Investigacion, desarrollo e innovacion, actividades cientificas y tecnicas, informacion y comunicacines, informatica, telecomunicaciones y o...
Perfil tecnológico
TRL
4-5
130K
Perfil tecnológico
TRL
4-5
130K